1-16 of 16
basal insulin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Initiation of iGlarLixi Versus Basal-Bolus Insulin in Adults With Type 2 Diabetes Advancing From Basal Insulin Therapy: The SoliComplex Real-World Study

Free
Kevin M. Pantalone, Caroline Heller, Rosemarie Lajara, Elisheva Lew, Xuan Li, Terry Dex, C. Rachel Kilpatrick
Journal: Diabetes Spectrum
Diabetes Spectr 2023;36(3):253–263
https://doi.org/10.2337/ds22-0064
Published: 07 March 2023
View articletitled, Initiation of iGlarLixi Versus Basal-Bolus Insulin in Adults With Type 2 Diabetes Advancing From Basal Insulin Therapy: The SoliComplex Real-World Study
Open the PDF for Initiation of iGlarLixi Versus Basal-Bolus Insulin in Adults With Type 2 Diabetes Advancing From Basal Insulin Therapy: The SoliComplex Real-World Study in another window
Journal Articles

Instituting a Successful Discharge Plan for Patients With Type 2 Diabetes: Challenges and Solutions

Free
Andrew P. Demidowich, Kristine Batty, Mihail Zilbermint
Journal: Diabetes Spectrum
Diabetes Spectr 2022;35(4):440–451
https://doi.org/10.2337/dsi22-0013
Published: 15 November 2022
View articletitled, Instituting a Successful Discharge Plan for Patients With Type 2 Diabetes: Challenges and Solutions
Open the PDF for Instituting a Successful Discharge Plan for Patients With Type 2 Diabetes: Challenges and Solutions in another window
Journal Articles

Inpatient Diabetes Management: Preface: Inpatient Diabetes Management: Should We Make It Simpler?

Free
Mihail Zilbermint
Journal: Diabetes Spectrum
Diabetes Spectr 2022;35(4):387–389
https://doi.org/10.2337/dsi22-0014
Published: 15 November 2022
View articletitled, Inpatient Diabetes Management: Preface: Inpatient Diabetes Management: Should We Make It Simpler?
Open the PDF for Inpatient Diabetes Management: Preface: Inpatient Diabetes Management: Should We Make It Simpler? in another window
Journal Articles

Use of Flash Continuous Glucose Monitoring Is Associated With A1C Reduction in People With Type 2 Diabetes Treated With Basal Insulin or Noninsulin Therapy

Free
Eugene E. Wright, Jr., Matthew S.D. Kerr, Ignacio J. Reyes, Yelena Nabutovsky, Eden Miller
Journal: Diabetes Spectrum
Diabetes Spectr 2021;34(2):184–189
https://doi.org/10.2337/ds20-0069
Published: 10 February 2021
View articletitled, Use of Flash Continuous Glucose Monitoring Is Associated With A1C Reduction in People With Type 2 Diabetes Treated With Basal Insulin or Noninsulin Therapy
Open the PDF for Use of Flash Continuous Glucose Monitoring Is Associated With A1C Reduction in People With Type 2 Diabetes Treated With Basal Insulin or Noninsulin Therapy in another window
Journal Articles

Challenges and Strategies for Inpatient Diabetes Management in Older Adults

Free
Aidar R. Gosmanov, Carlos E. Mendez, Guillermo E. Umpierrez
Journal: Diabetes Spectrum
Diabetes Spectr 2020;33(3):227–235
https://doi.org/10.2337/ds20-0008
Published: 01 August 2020
View articletitled, Challenges and Strategies for Inpatient Diabetes Management in Older Adults
Open the PDF for Challenges and Strategies for Inpatient Diabetes Management in Older Adults in another window
Journal Articles

Achievement of Target A1C <7.0% (<53 mmol/mol) by U.S. Type 2 Diabetes Patients Treated With Basal Insulin in Both Randomized Controlled Trials and Clinical Practice

Open Access
Lawrence Blonde, Stephen A. Brunton, Pavan Chava, Rong Zhou, Juliana Meyers, Keith L. Davis, Mehul R. Dalal, Andres DiGenio
Journal: Diabetes Spectrum
Diabetes Spectr 2019;32(2):93–103
https://doi.org/10.2337/ds17-0082
Published: 01 May 2019
View articletitled, Achievement of Target A1C &lt;7.0% (&lt;53 mmol/mol) by U.S. Type 2 Diabetes Patients Treated With Basal Insulin in Both Randomized Controlled Trials and Clinical Practice
Open the PDF for Achievement of Target A1C <7.0% (<53 mmol/mol) by U.S. Type 2 Diabetes Patients Treated With Basal Insulin in Both Randomized Controlled Trials and Clinical Practice in another window
Includes: Supplementary data
Journal Articles

Insulin Initiation and Titration in Patients With Type 2 Diabetes

Open Access
Ji Chun, Jodi Strong, Scott Urquhart
Journal: Diabetes Spectrum
Diabetes Spectr 2019;32(2):104–111
https://doi.org/10.2337/ds18-0005
Published: 01 May 2019
View articletitled, Insulin Initiation and Titration in Patients With Type 2 Diabetes
Open the PDF for Insulin Initiation and Titration in Patients With Type 2 Diabetes in another window
Journal Articles

Erratum: Short-Term Outcomes for Veterans Receiving Basal Insulin, Metformin, and a Sulfonylurea Who Are Started on a Third Noninsulin Agent Versus Prandial Insulin. Diabetes Spectrum 2018;31: 261–266 ( doi.org/10.2337/ds17-0068 )

Open Access
Andrew D. Santeusanio, Monica M. Bowen
Journal: Diabetes Spectrum
Diabetes Spectr 2018;31(4):367
https://doi.org/10.2337/ds18-er04
Published: 01 November 2018
View articletitled, Erratum: Short-Term Outcomes for Veterans Receiving Basal Insulin, Metformin, and a Sulfonylurea Who Are Started on a Third Noninsulin Agent Versus Prandial Insulin. Diabetes Spectrum 2018;31: 261–266 ( doi.org/10.2337/ds17-0068 )
Open the PDF for Erratum: Short-Term Outcomes for Veterans Receiving Basal Insulin, Metformin, and a Sulfonylurea Who Are Started on a Third Noninsulin Agent Versus Prandial Insulin. Diabetes Spectrum 2018;31: 261–266 ( doi.org/10.2337/ds17-0068 ) in another window
Journal Articles

Short-Term Outcomes for Veterans Receiving Basal Insulin, Metformin, and a Sulfonylurea Who Are Started on a Third Noninsulin Agent Versus Prandial Insulin

Open Access
Andrew D. Santeusanio, Monica M. Bowen
Journal: Diabetes Spectrum
Diabetes Spectr 2018;31(3):261–266
https://doi.org/10.2337/ds17-0068
Published: 01 August 2018
View articletitled, Short-Term Outcomes for Veterans Receiving Basal Insulin, Metformin, and a Sulfonylurea Who Are Started on a Third Noninsulin Agent Versus Prandial Insulin
Open the PDF for Short-Term Outcomes for Veterans Receiving Basal Insulin, Metformin, and a Sulfonylurea Who Are Started on a Third Noninsulin Agent Versus Prandial Insulin in another window
Journal Articles

Effectiveness and Tolerability of Therapy With Once-Weekly Exenatide Versus Basal Insulin Among Injectable-Naive Patients With Type 2 Diabetes in a Real-World Setting in the United States

Open Access
Anita M. Loughlin, Qing Qiao, Anthony P. Nunes, Stephen M. Ezzy, Laura Yochum, C. Robin Clifford, Robert V. Gately, David D. Dore, John D. Seeger
Journal: Diabetes Spectrum
Diabetes Spectr 2018;31(2):129–137
https://doi.org/10.2337/ds16-0081
Published: 01 May 2018
View articletitled, Effectiveness and Tolerability of Therapy With Once-Weekly Exenatide Versus Basal Insulin Among Injectable-Naive Patients With Type 2 Diabetes in a Real-World Setting in the United States
Open the PDF for Effectiveness and Tolerability of Therapy With Once-Weekly Exenatide Versus Basal Insulin Among Injectable-Naive Patients With Type 2 Diabetes in a Real-World Setting in the United States in another window
Journal Articles

iGlarLixi: A New Once-Daily Fixed-Ratio Combination of Basal Insulin Glargine and Lixisenatide for the Management of Type 2 Diabetes

Open Access
Debbie Hinnen, Jodi Strong
Journal: Diabetes Spectrum
Diabetes Spectr 2018;31(2):145–154
https://doi.org/10.2337/ds17-0014
Published: 01 May 2018
View articletitled, iGlarLixi: A New Once-Daily Fixed-Ratio Combination of Basal Insulin Glargine and Lixisenatide for the Management of Type 2 Diabetes
Open the PDF for iGlarLixi: A New Once-Daily Fixed-Ratio Combination of Basal Insulin Glargine and Lixisenatide for the Management of Type 2 Diabetes in another window
Journal Articles

Basal Insulin Use With GLP-1 Receptor Agonists

Open Access
Sarah L. Anderson, Jennifer M. Trujillo
Journal: Diabetes Spectrum
Diabetes Spectr 2016;29(3):152–160
https://doi.org/10.2337/diaspect.29.3.152
Published: 01 August 2016
View articletitled, Basal Insulin Use With GLP-1 Receptor Agonists
Open the PDF for Basal Insulin Use With GLP-1 Receptor Agonists in another window
Journal Articles

Case Study: Remission of Type 2 Diabetes After Outpatient Basal Insulin Therapy

Open Access
Sierra C. Schmidt, Martha Ann Huey, Heather P. Whitley
Journal: Diabetes Spectrum
Diabetes Spectr 2016;29(1):50–53
https://doi.org/10.2337/diaspect.29.1.50
Published: 01 February 2016
View articletitled, Case Study: Remission of Type 2 Diabetes After Outpatient Basal Insulin Therapy
Open the PDF for Case Study: Remission of Type 2 Diabetes After Outpatient Basal Insulin Therapy in another window
Journal Articles

Prevention of Exercise-Associated Dysglycemia: A Case Study–Based Approach

Open Access
Dessi P. Zaharieva, Michael C. Riddell
Journal: Diabetes Spectrum
Diabetes Spectr 2015;28(1):55–62
https://doi.org/10.2337/diaspect.28.1.55
Published: 01 February 2015
View articletitled, Prevention of Exercise-Associated Dysglycemia: A Case Study–Based Approach
Open the PDF for Prevention of Exercise-Associated Dysglycemia: A Case Study–Based Approach in another window
Journal Articles

Insulin Initiation During a 20-Minute Office Visit: Part 2: Making It Happen

Free
Virginia Valentine, CNS, BC-ADM, CDE
Journal: Diabetes Spectrum
Diabetes Spectr 2010;23(4):260–266
https://doi.org/10.2337/diaspect.23.4.260
Published: 01 January 2010
View articletitled, Insulin Initiation During a 20-Minute Office Visit: Part 2: Making It Happen
Open the PDF for Insulin Initiation During a 20-Minute Office Visit: Part 2: Making It Happen in another window
Journal Articles

Glargine: A New Basal Insulin, A New Opportunity

Free
Richard A. Guthrie, MD, FAAP, FACE, CDE, Deborah Hinnen, MN, ARNP, CDE, Belinda P. Childs, MN, ARNP, CDE
Journal: Diabetes Spectrum
Diabetes Spectr 2001;14(3):120–122
https://doi.org/10.2337/diaspect.14.3.120
Published: 01 August 2001
View articletitled, Glargine: A New Basal Insulin, A New Opportunity
Open the PDF for Glargine: A New Basal Insulin, A New Opportunity in another window